dr. mirza discusses niraparib dose modifications for ovarian cancer patients with low body weight
Published 6 years ago • 381 plays • Length 2:26Download video MP4
Download video MP3
Similar videos
-
1:30
dr. mirza on niraparib efficacy across ovarian cancer subgroups
-
2:18
dr. mirza on efficacy of niraparib/bevacizumab combo in recurrent ovarian cancer
-
1:41
dr. mirza on niraparib plus bevacizumab combo in ovarian cancer
-
0:57
analyzing the survival benefits of niraparib dose modification in ovarian cancer
-
0:57
dr. mirza on impact of niraparib in ovarian cancer
-
0:52
dr. mirza on safety profile of niraparib/bevacizumab in recurrent ovarian cancer
-
1:50
niraparib shows positive data, requires different dosing in ovarian cancer
-
1:35
dr. mirza on the phase iii nova trial in ovarian cancer
-
1:14
dr. arend on niraparib with bevacizumab in ovarian cancer
-
3:14
personalized dosing of niraparib in ovarian cancer
-
3:08
ovarian cancer: optimizing treatment with niraparib
-
6:57
niraparib maintenance for recurrent ovarian cancer
-
1:18
dr. pothuri on patient-reported outcomes with niraparib in advanced ovarian cancer
-
2:20
dr. matulonis discusses niraparib/pembrolizumab combo in platinum-resistant ovarian cancer
-
1:38
dr. chase on niraparib as frontline maintenance therapy in ovarian cancer
-
3:23
niraparib significantly improves outcomes for ovarian cancer patients
-
3:11
the avanova study: niraparib and bevacizumab for ovarian cancer
-
2:35
clinical use of niraparib in ovarian cancer
-
1:54
management of niraparib dosing in ovarian cancer